The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 13, 2025
Filed:
Mar. 31, 2017
Applicant:
Immutrix Therapeutics, Inc., Rapid City, SD (US);
Inventors:
Carol A. Rae, Rapid City, SD (US);
Jan Simoni, Rapid City, SD (US);
John F. Moeller, Rapid City, SD (US);
Assignee:
Immutrix Therapeutics, Inc., Rapid City, SD (US);
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/36 (2006.01); A61K 33/44 (2006.01); A61M 1/34 (2006.01); B01D 15/00 (2006.01); B01J 20/20 (2006.01); B01J 20/26 (2006.01); B01J 20/28 (2006.01); B01J 20/32 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3679 (2013.01); A61K 33/44 (2013.01); A61M 1/3486 (2014.02); B01D 15/00 (2013.01); B01J 20/20 (2013.01); B01J 20/265 (2013.01); B01J 20/28016 (2013.01); B01J 20/28052 (2013.01); B01J 20/28092 (2013.01); B01J 20/3204 (2013.01); B01J 20/321 (2013.01); B01J 20/3212 (2013.01); B01J 20/3242 (2013.01); B01J 20/3293 (2013.01);
Abstract
A three-component composition for use in the treatment of preeclampsia and related disorders wherein a first component comprises a bimodal synthetic carbon particle mixture; a second component comprises a resin bead with at least one affinity ligand directed toward syncytiotrophoblast-derived factor sEndoglin and a third component comprises a resin bead with at least one affinity ligand directed toward syncytiotrophoblast-derived factor soluble Fms-like tyrosine kinase-1.